SSA
ELV icon

Schonfeld Strategic Advisors’s Elevance Health ELV Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
+4,600
New +$1.71M 0.01% 1129
2024
Q3 		– Sell
-8,000
Closed -$4.33M – 2135
2024
Q2 		$4.33M Buy
+8,000
New +$4.23M 0.03% 597

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Schonfeld Strategic Advisors's ELV Position: Q2 2026 in Review

Schonfeld Strategic Advisors reduced its Elevance Health (ELV) stake by 91% in Q2 2026, selling an estimated $28.2M and leaving 7,764 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #864.

Schonfeld Strategic Advisors first reported a position in ELV in Q2 2017 and has held it in 32 quarters since. The position peaked at $47.5M in Q3 2022. 1,611 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Schonfeld Strategic Advisors held 7,764 shares of Elevance Health worth $3M as of Q2 2026.
  • Schonfeld Strategic Advisors sold 76,113 Elevance Health shares in Q2 2026, an estimated $28.2M.
  • Elevance Health made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #864 holding.
  • Schonfeld Strategic Advisors first reported a position in Elevance Health in Q2 2017 and has held it in 32 quarters since.
  • Schonfeld Strategic Advisors's Elevance Health position peaked at $47.5M in Q3 2022.
  • 1,611 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.